Read + Share
Gooderham MJ, Mrowietz U, Kadus W, Drda K, et al. Phase II Randomized Trial of BI 730357, a Novel Oral RORgammat Inhibitor, for
Moderate-to-Severe Plaque Psoriasis. J Invest Dermatol 2025 Jan 21:S0022-202X(25)00034.
PMID: 39848568
|
 |
|
Gooderham MJ, Mrowietz U, Kadus W, Drda K, et al. Phase II Randomized Trial of BI 730357, a Novel Oral RORgammat Inhibitor, for
Moderate-to-Severe Plaque Psoriasis. J Invest Dermatol 2025 Jan 21:S0022-202X(25)00034.
PMID: 39848568
|
|
|
|